Tharimmune Inc.

THAR•United States

Healthcare United States Pharmaceutical Preparations

Need professional-grade analysis? Visit stockanalysis.com

$3.33

-18.30%

End of day

Market Cap

$187.37M

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	3.02	0.55	1.49	—	1.56
Calmar	—	—	6.12	0.83	1.65	—	2.49
Sharpe	—	—	2.04	0.37	0.46	—	0.83
Omega	—	—	1.34	1.15	1.39	—	1.30
Martin	—	—	17.15	1.54	2.62	—	5.89
Ulcer	—	—	14.03	25.51	44.82	—	30.69

Tharimmune Inc. (THAR) Price Performance

Tharimmune Inc. (THAR) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $3.33, down 18.30% from the previous close.

Over the past year, THAR has traded between a low of $1.05 and a high of $7.71. The stock has gained 130.9% over this period. It is currently 56.9% below its 52-week high.

Tharimmune Inc. has a market capitalization of $187.37M.

About Tharimmune Inc.

Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.

Company Info

Sector: Healthcare
Industry: Pharmaceutical Preparations
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): -3.68
Book Value: 0.85

Technical Indicators

52 Week High: $9.08
52 Week Low: $0.95
50 Day MA: $3.85
200 Day MA: $2.82
Beta: 1.45

Valuation

Trailing P/E: N/A
Forward P/E: -39.50
Price/Sales: N/A
Price/Book: 5.55
Enterprise Value: $166.06M